Cell and Gene Therapy Manufacturing Market Size, Share, Trends, Growth and Forecast 2032

Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market - By Therapy Type (Cell Therapy Manufacturing and Gene Therapy Manufacturing), By Scale (R&D and Commercial), By Workflow (Vector Production and Cell Banking), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Biotechnology Report Format : PDF Pages: 150 Report Code: ZMR-6498 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.11 Billion USD 4.77 Billion 9.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
    • 2.2. Cell and Gene Therapy Manufacturing Market: Snapshot
  • Chapter 3. Global Cell and Gene Therapy Manufacturing Market– Workflow Analysis
    • 3.1. Cell and Gene Therapy Manufacturing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Emergence of new drug treatment has brought a revulution in biopharma sector and is expected to bring swift transformation in treatment modes of life-threatening & rare disease, thereby translating into cell and gene therapy manufacturing market expansion in forthcoming years.
      • 3.2.2. Rapid spread of COVID-19 virus across the globe has resulted in massive elevation of cell and gene therapy manufacturing market size.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Workflow
      • 3.4.2. Market attractiveness analysis By Therapy Type
      • 3.4.3. Market attractiveness analysis By Scale
  • Chapter 4. Global Cell and Gene Therapy Manufacturing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Cell and Gene Therapy Manufacturing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Cell and Gene Therapy Manufacturing Market– Workflow Analysis
    • 5.1. Global Cell and Gene Therapy Manufacturing Market overview: By Workflow
      • 5.1.1. Global Cell and Gene Therapy Manufacturing Market share, By Workflow , 2020 and 2028
    • 5.2. Vector Production
      • 5.2.1. Global Cell and Gene Therapy Manufacturing Market by Vector Production, 2018–2028(USD Billion)
    • 5.3. Cell Banking
      • 5.3.1. Global Cell and Gene Therapy Manufacturing Market by Cell Banking, 2018–2028(USD Billion)
  • Chapter 6. Global Cell and Gene Therapy Manufacturing Market– Therapy Type Analysis
    • 6.1. Global Cell and Gene Therapy Manufacturing Market overview: By Therapy Type
      • 6.1.1. Global Cell and Gene Therapy Manufacturing Market share, By Therapy Type , 2020 and 2028
    • 6.2. Cell Therapy Manufacturing
      • 6.2.1. Global Cell and Gene Therapy Manufacturing Market by Cell Therapy Manufacturing, 2018–2028(USD Billion)
    • 6.3. Gene Therapy Manufacturing
      • 6.3.1. Global Cell and Gene Therapy Manufacturing Market by Gene Therapy Manufacturing, 2018–2028(USD Billion)
  • Chapter 7. Global Cell and Gene Therapy Manufacturing Market– Scale Analysis
    • 7.1. Global Cell and Gene Therapy Manufacturing Market overview: By Scale
      • 7.1.1. Global Cell and Gene Therapy Manufacturing Market share, By Scale, 2020 and 2028
    • 7.2. R&D
      • 7.2.1. Global Cell and Gene Therapy Manufacturing Market by R&D, 2018–2028(USD Billion)
    • 7.3. Commercial
      • 7.3.1. Global Cell and Gene Therapy Manufacturing Market by Commercial, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Lonza AG
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Thermo Fisher Scientific
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Merck KGaA
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Catalent Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Roche Diagnostics Limited
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Takara Bio Incorporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Boehringer Ingelheim
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Wuxi Advanced Therapeutics
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Novartis AG
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Hitachi Chemical Company Limited
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Bluebird Bio Inc.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Cellular Therapeutics
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cell and Gene Therapy Manufacturing Marketattractiveness, By Workflow
6. Global Cell and Gene Therapy Manufacturing Marketattractiveness, By Therapy Type 
7. Global Cell and Gene Therapy Manufacturing Marketattractiveness, By Scale
8. Global Cell and Gene Therapy Manufacturing Marketshare by Workflow ,2020 and 2028 (USD Billion)
9. Global Cell and Gene Therapy Manufacturing Marketby Vector Production, 2018–2028(USD Billion)
10. Global Cell and Gene Therapy Manufacturing Marketby Cell Banking, 2018–2028(USD Billion)
11. Global Cell and Gene Therapy Manufacturing Marketshare by Therapy Type  ,2020 and 2028 (USD Billion)
12. Global Cell and Gene Therapy Manufacturing Marketby Cell Therapy Manufacturing, 2018–2028(USD Billion)
13. Global Cell and Gene Therapy Manufacturing Marketby Gene Therapy Manufacturing, 2018–2028(USD Billion)
14. Global Cell and Gene Therapy Manufacturing Marketshare by Scale ,2020 and 2028 (USD Billion)
15. Global Cell and Gene Therapy Manufacturing Marketby R&D, 2018–2028(USD Billion)
16. Global Cell and Gene Therapy Manufacturing Marketby Commercial, 2018–2028(USD Billion)
17. Global Cell and Gene Therapy Manufacturing Marketshare, by Region, 2020 and 2028
18. North America Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
19. Europe Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
20. Asia Pacific Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
21. Latin America Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
22. The Middle East and Africa Cell and Gene Therapy Manufacturing Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Cell and Gene Therapy Manufacturing Market: snapshot
2. Drivers of the Cell and Gene Therapy Manufacturing Market: impact analysis
3. North America Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
4. North America Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
5. North America Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
6. The U.S. Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
7. The U.S. Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
8. The U.S. Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
9. Rest of North America Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
10. Rest of North America Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
11. Rest of North America Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
12. Europe Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
13. Europe Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
14. Europe Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
15. UK Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
16. UK Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
17. UK Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
18. France Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
19. France Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
20. France Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
21. Germany Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
22. Germany Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
23. Germany Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
24. Rest of Europe Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
25. Rest of Europe Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
26. Rest of Europe Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
27. Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
28. Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
29. Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
30. China Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
31. China Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
32. China Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
33. Japan Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
34. Japan Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
35. Japan Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
36. India Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
37. India Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
38. India Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
39. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
40. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
41. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
42. Latin America Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
43. Latin America Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
44. Latin America Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
45. Brazil Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
46. Brazil Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
47. Brazil Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
48. Rest of Latin America Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
49. Rest of Latin America Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
50. Rest of Latin  America Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
51. The Middle East and Africa Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
52. The Middle East and Africa Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
53. The Middle East and Africa Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
54. Saudi Arabia Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
55. Saudi Arabia Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
56. Saudi Arabia Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
57. South Africa Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
58. South Africa Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
59. South Africa Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Cell and Gene Therapy Manufacturing Market revenue, By Workflow  ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Cell and Gene Therapy Manufacturing Market revenue, By Therapy Type   ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Cell and Gene Therapy Manufacturing Market revenue, By Scale  ,2018–2028(USD Billion)
 
 

Methodology

FrequentlyAsked Questions

This manufacturing produces advanced genetic therapies. It supports treatment of complex diseases
The global Cell and Gene Therapy Manufacturing market is expected to be driven by the advancements in regenerative medicine and personalized therapies. Increasing clinical trials and investment support expansion.
According to study, the global Cell and Gene Therapy Manufacturing market size was worth around USD 2.11 Billion in 2023 and is predicted to grow to around USD 4.77 Billion By 2032.
The global Cell and Gene Therapy Manufacturing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 9.5% during the forecast period from 2024-2032.
The global Cell and Gene Therapy Manufacturing industry is projected to be challenged by Challenges include complex manufacturing, high capital costs, and regulatory hurdles.
The Opportunities include advanced therapeutics pipelines, outsourcing demand, rare disease treatments, and biopharma investment growth will offer significant growth opportunities in the Cell and Gene Therapy Manufacturing market.
Scalable viral vector production; closed-system and automated bioprocessing; quality-by-design manufacturing approaches are the emerging trends and innovations impacting the Cell and Gene Therapy Manufacturing market.
The global Cell and Gene Therapy Manufacturing market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Cell and Gene Therapy Manufacturing market are; Lonza AG, Thermo Fisher Scientific, Merck KGaA, Catalent Inc., Roche Diagnostics Limited, Takara Bio Incorporation, Boehringer Ingelheim, Wuxi Advanced Therapeutics, Novartis AG, Hitachi Chemical Company Limited, Bluebird Bio Inc., and Cellular Therapeutics. and others.
The report explores crucial aspects of the Cell and Gene Therapy Manufacturing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market InsightsSynopsisGrowth DynamicsRegional LandscapeReport ScopeCompetitive LandscapeThe global Market is segmented as follows:

HappyClients